In contrast, DRM/Gremlin methylation was detected in 11/15 (73%) of NSCLC cell lines, 4/13 (31%) of SCLC cell lines, 5/10 (50%) of breast cancer cell lines, and 4/6 (67%) of MM cell lines. This evidence concerns the gene GREM1 and Miyoshi myopathy.